v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net loss $ (4,508) $ (10,258)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 54,777 48,462
Gain on extinguishment of debt (4,383)  
Deferred income taxes (2,890) 2,800
Theatre and other closure expense 1,365 1,438
Gain on dispositions (460) (4,991)
Stock based compensation 6,357  
Equity in earnings and losses from non-consolidated entities, net of distributions 14,165 5,828
Landlord contributions 11,294  
Change in assets and liabilities:    
Receivables 45,241 41,325
Other assets (2,244) (2,498)
Accounts payable (51,710) (4,897)
Accrued expenses and other liabilities (76,595) (38,504)
Other, net 8,016 (2,823)
Net cash provided by (used in) operating activities (1,575) 35,882
Cash flows from investing activities:    
Capital expenditures (55,599) (39,350)
Investments in non-consolidated entities, net (721) (2,671)
Acquisition of Rave theatres   (315)
Proceeds (payments) from the disposition of long-term assets (128) 4,991
Other, net (1,783) (956)
Net cash used in investing activities (58,231) (38,301)
Cash flows from financing activities:    
Proceeds from issuance of Senior Subordinated Notes due 2022 375,000  
Repurchase of Senior Subordinated Notes due 2019 (496,903)  
Payment of initial public offering costs (281)  
Deferred financing costs (7,568) (175)
Principal payments under capital and financing lease obligations (1,672) (1,511)
Principal payments under Term Loan (1,938) (2,001)
Payment of construction payables   (20,541)
Net cash used in financing activities (133,362) (24,228)
Effect of exchange rate changes on cash and equivalents (9) (48)
Net decrease in cash and equivalents (193,177) (26,695)
Cash and equivalents at beginning of period 544,311 130,928
Cash and equivalents at end of period $ 351,134 $ 104,233